Advertisement

Intuitive Surgical defends its adverse event reports, which analysts at Citron Group call a 'gross misuse of statistical data.'

Citron puts Intuitive Surgical on blast over adverse events

The battle between surgical devices maker Intuitive Surgical (NSDQ:ISRG) and analysts at Citron Group continues to heat up, with harsh words from one and a stern defense from the other.

Citron Group today issued an open letter to Intuitive Surgical, accusing the company of misusing FDA data to falsely paint a picture of declining adverse events associated with the da Vinci surgical robot.

Advertisement
Advertisement